CHD4 and cancer: Our detailed mechanistic analysis of cancer-derived dMi-2/CHD4 mutants has revealed defects in different structural domains resulting in diverse effects including lower ATPase activity, decreased nucleosome binding, inefficient coupling of ATPase and remodelling activities and altered nucleosome positioning.